Programme

Keywords
PDF version

Wed 23 Oct

10:00

e-poster session day 1

to
Digital kiosks
e-poster session

11:50

Cannabis legalisation in Canada and the US: policy variation, state of the evidence and ideas for future research

to
Auditorium I
Major session

Lives at risk: mental health and substance use

to
Auditorium VII
Oral presentation session

Prevalence of opioids and related harms

to
Auditorium VIII
Oral presentation session

Support for recovery

to
Room 1.07
Short communication session

Evaluation of drug consumption rooms: guidance step by step

to
Room 1.15
Workshop

14:20

Neuroscience and cognition

to
Auditorium III
Short communication session

Legal shifts and their Impact on drug use and sentencing

to
Auditorium IV
Oral presentation session

Gender and substance use

to
Auditorium VIII
Oral presentation session

Challenge of measuring use and impact of cannabinoids

to
Room 1.07
Oral presentation session

16:00

Measuring drug market phenomenon

to
Auditorium VI
Oral presentation session

Assessment of behavioural addictions

to
Room 5B
Oral presentation session

Quality in addictions work systems

to
Room 1.06
Oral presentation session

Conceptualising health and harms

to
Room 1.08
Short communication session

17:50

Strengthening quality in substance use disorders treatment

to
Auditorium II
Oral presentation session

NPS: trends, concerns and response strategies

to
Auditorium III
Oral presentation session

Drug use trends

to
Auditorium IV
Oral presentation session

Decriminalisation and alternatives to arrest

to
Auditorium VI
Oral presentation session

Psychedelics 1

to
Auditorium VIII
Oral presentation session

Hepatitis C, HIV, and other drug related harms

to
Room 1.05
Short communication session

Opioids: trends, use and treatments

to
Room 1.06
Short communication session

Thu 24 Oct

10:00

Expert knowledge elicitation to complement and enhance data collection and monitoring efforts.

to
Room 1.10
Workshop

Workshop on conducting drug research in prison: Challenges and key recommendations from the European experience

to
Room 1.15
Workshop

11:50

Opioid Agonist Treatment: novel formulations and challenges

to
Auditorium IV
Oral presentation session

Evidence informed drug and alcohol policy

to
Auditorium VI
Oral presentation session

Emerging drug harms, DCRs and other responses

to
Auditorium VII
Short communication session

Innovative methods for understanding drug markets and policy

to
Room 5A
Oral presentation session

Contemporary issues

to
Room 1.08
Oral presentation session

14:20

Understanding harm reduction: economic, social, and health perspectives

to
Room 1.05
Short communication session

European prevention curriculum: increasing the use of evidence-based prevention

to
Room 1.06
Short communication session

16:00

NPS: Pharmacological Characterization and Substance Analysis

to
Auditorium III
Oral presentation session

Hepatitis C testing and treatment

to
Auditorium IV
Oral presentation session

How can treatment be a better experience?

to
Auditorium VII
Oral presentation session

City insights: creating a collaborative network for city-level monitoring of drug trends and harm reduction

to
Room 1.07
Workshop

Drug trends: experiences from Brazil, the Netherlands, Portugal, and Spain

to
Room 1.08
Oral presentation session

How to respond to real-time drug alerts in European countries ?

to
Room 1.15
Workshop

17:50

Viral hepatitis among people who inject drugs

to
Auditorium IV
Oral presentation session

Hospital-based treatments

to
Room 5B
Oral presentation session

From old to new: changes in drug use

to
Room 5C
Oral presentation session

Newly Regulated Markets, Managing Harms, Treatment & Advocating for Reform

to
Room 1.06
Short communication session

A two-phased augmentation/intervention extension of Claremont’s media-based prevention education model

to
Room 1.10
Workshop

Fri 25 Oct

11:50

Alcohol: interventions and up-to-date technologies

to
Auditorium II
Oral presentation session

Drugs checking services

to
Room 5A
Oral presentation session

Online monitoring

to
Room 5B
Oral presentation session

Substance use and treatment needs across European prisons

to
Room 5C
Oral presentation session

Emerging challenges in drug markets: monitoring, measurement & impacts

to
Room 1.05
Short communication session

How can cannabis policy goals inform the development of evaluation indicators?

to
Room 1.08
Workshop

14:20

Addressing diverse treatment needs

to
Auditorium VI
Oral presentation session

Substance use and mental health in prison settings

to
Auditorium VII
Oral presentation session

Regulating cannabis supply policies in Europe: navigating the long road to change

to
Auditorium VIII
Oral presentation session

Holistic care for mental well-being

to
Room 1.05
Short communication session

16:00

Novel psychoactive substances and latest drug trends in Asia and Pacific countries

to
Room 1.05
Oral presentation session